Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul;88(7):873-6.
doi: 10.1136/bjo.2003.034256.

National survey of antimetabolite use in glaucoma surgery in the United Kingdom

D Siriwardena  1 , B Edmunds, R P L Wormald, P T Khaw
Affiliations

National survey of antimetabolite use in glaucoma surgery in the United Kingdom

D Siriwardena et al. Br J Ophthalmol. 2004 Jul.

Abstract

Aims: To assess the pattern of use of antimetabolites in trabeculectomy surgery by all consultant ophthalmologists in the United Kingdom.

Methods: A postal questionnaire of 12 questions regarding antimetabolite use in trabeculectomy surgery was sent to all 749 consultant ophthalmologists in the United Kingdom. The consultants were asked to estimate the number of trabeculectomies they performed per year, how often they used 5-fluorouracil (5-FU) in primary and redo surgery, their usual method of administration of 5-FU, how often they used mitomycin (MMC) in primary and redo surgery, and their usual dosage regimen of MMC. Factors that influenced the decision to use or not use antimetabolites were also assessed.

Results: The response rate of consultants returning the questionnaire was 82% (615 out of 749); 87% (533) of these consultants perform trabeculectomy surgery. Of these 533 consultants, 98 (18%) never use an antimetabolite. Most consultants (82%) use antimetabolites, but use them infrequently (only 9% using antimetabolites in more than half their cases). The preferred antimetabolite is 5-FU rather than MMC. Of the 435 consultants performing trabeculectomy surgery and using antimetabolites, 402 (93%) use 5-FU and 179 (41%) use MMC. Various factors influenced the decision to use or not use an antimetabolite, but experience of complications associated with their use was a factor for 34% of consultants.

Conclusion: The use of antimetabolites, particularly MMC, in the United Kingdom is much less than in America or Japan, where trabeculectomy with MMC is the surgical procedure preferred by glaucoma specialists.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of antimetabolite use in trabeculectomy.
Figure 2
Figure 2
Frequency of antimetabolite use in first time and redo trabeculectomy.
Figure 3
Figure 3
Technique of 5-FU administration.
Figure 4
Figure 4
Frequency of MMC use in trabeculectomy.
Figure 5
Figure 5
Concentration of MMC used.
Figure 6
Figure 6
Time of MMC application.
See this image and copyright information in PMC

Comment in

  • Trabeculectomy and antimetabolites.
    Fraser S. Fraser S. Br J Ophthalmol. 2004 Jul;88(7):855-6. doi: 10.1136/bjo.2004.040055. Br J Ophthalmol. 2004. PMID: 15205223 Free PMC article. No abstract available.

References

    1. Hitchings R , Grierson I. Clinicopathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK 1983;103:84–8. - PubMed
    1. Addicks E , Quigley H, Green W, et al. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983;101:795–8. - PubMed
    1. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5FU. Am J Ophthalmol 1992;114:544–53. - PubMed
    1. Wolner B , Liebmann JM, Sassani JW, et al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology 1991;98:1053–60. - PubMed
    1. Edmunds B , Thompson JR, Salmon JF, et al. The National Survey of Trabeculectomy. II. Variations in operative technique and outcome. Eye 2001;15:441–8. - PubMed

Publication types

MeSH terms